Cbs Chemicals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 16-11-2024
- Paid Up Capital ₹ 0.10 M
as on 16-11-2024
- Company Age 3 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Revenue -25.59%
(FY 2023)
- Profit 54.51%
(FY 2023)
- Ebitda 338.89%
(FY 2023)
- Net Worth 151.92%
(FY 2023)
- Total Assets -13.72%
(FY 2023)
About Cbs Chemicals
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Ajaykarthik Ganapathy and Sundaramurthy Sandhya serve as directors at the Company.
- CIN/LLPIN
U24231KA2021PTC144349
- Company No.
144349
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Feb 2021
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Cbs Chemicals Private Limited offer?
Cbs Chemicals Private Limited offers a wide range of products and services, including Natural and Synthetic Resins, Curing Agent, Cement and Concrete, Concrete Admixture, Adhesives, Glue and Sealants, Bonding Agents, Waterproofing Chemicals, SBR Latex, Construction Chemical, Integral Waterproofing Compound.
Who are the key members and board of directors at Cbs Chemicals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ajaykarthik Ganapathy  | Director | 19-Feb-2021 | Current |
| Sundaramurthy Sandhya | Director | 19-Feb-2021 | Current |
Financial Performance of Cbs Chemicals.
Cbs Chemicals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 25.59% decrease. The company also saw a substantial improvement in profitability, with a 54.51% increase in profit. The company's net worth Soared by an impressive increase of 151.92%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cbs Chemicals?
Unlock access to Cbs Chemicals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Cbs Chemicals?
Cbs Chemicals has a workforce of 24 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cbs Chemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cbs Chemicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
